Virtus ETF Advisers LLC Kymera Therapeutics, Inc. Transaction History

Virtus ETF Advisers LLC

$206 Million
Q3 2024

A detailed history of Virtus ETF Advisers LLC transactions in Kymera Therapeutics, Inc. stock. As of the latest transaction made, Virtus ETF Advisers LLC holds 2,640 shares of KYMR stock, worth $103,118. This represents 0.06% of its overall portfolio holdings.

Number of Shares

2,640

Previous 2,596 1.69%

Holding current value

$103,118

Previous $77,000 61.04%

% of portfolio

0.06%

Previous 0.04%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$30.16 - $52.4 $1,327 - $2,305	44 Added 1.69%	2,640 $124,000
Q2 2024 Aug 14, 2024	SELL	$29.85 - $39.42 $24,208 - $31,969	-811 Reduced 23.8%	2,596 $77,000
Q1 2024 May 15, 2024	SELL	$22.9 - $43.57 $5,289 - $10,064	-231 Reduced 6.35%	3,407 $136,000
Q4 2023 Feb 15, 2024	SELL	$10.97 - $26.84 $2,183 - $5,341	-199 Reduced 5.19%	3,638 $92,000
Q3 2023 Nov 07, 2023	SELL	$13.9 - $23.88 $5,254 - $9,026	-378 Reduced 8.97%	3,837 $53,000
Q2 2023 Aug 14, 2023	BUY	$22.4 - $34.92 $17,830 - $27,796	796 Added 23.28%	4,215 $96,000
Q1 2023 May 15, 2023	SELL	$24.84 - $38.75 $32,540 - $50,762	-1,310 Reduced 27.7%	3,419 $101,000
Q4 2022 Feb 14, 2023	SELL	$19.57 - $30.92 $48,788 - $77,083	-2,493 Reduced 34.52%	4,729 $118,000
Q3 2022 Nov 14, 2022	BUY	$20.91 - $34.27 $1,066 - $1,747	51 Added 0.71%	7,222 $157,000
Q2 2022 Aug 12, 2022	BUY	$14.13 - $42.55 $60,377 - $181,816	4,273 Added 147.45%	7,171 $141,000
Q1 2022 May 16, 2022	SELL	$35.3 - $64.68 $6,106 - $11,189	-173 Reduced 5.63%	2,898 $123,000
Q4 2021 Feb 14, 2022	SELL	$49.91 - $65.56 $56,597 - $74,345	-1,134 Reduced 26.97%	3,071 $195,000
Q3 2021 Nov 15, 2021	SELL	$47.8 - $66.66 $10,324 - $14,398	-216 Reduced 4.89%	4,205 $247,000
Q2 2021 Aug 10, 2021	BUY	$31.08 - $51.95 $137,404 - $229,670	4,421 New	4,421 $214,000

Others Institutions Holding KYMR

# of Institutions

184

Shares Held

64.4M

Call Options Held

50.6K

Put Options Held

81.7K

View Full List

About Kymera Therapeutics, Inc.

Ticker KYMR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 54,705,800
Market Cap $2.14B
Description
Kymera Therapeutics, Inc., a biopharmaceutical company, focuses on discovering and developing novel small molecule therapeutics that selectively degrade disease-causing proteins by harnessing the body's own natural protein degradation system. It engages in developing IRAK4 program, which is in Phase I clinical trial for the treatment of immunolo...

More about KYMR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Virtus ETF Advisers LLC, based on Form 13F filings with the SEC.

News

Stay updated on Virtus ETF Advisers LLC with notifications on news.

Account

Virtus ETF Advisers LLC Kymera Therapeutics, Inc. Transaction History